The Menopause Check from MyBody-X measures hormones like FSH, estradiol, and AMH, which indicate the transition into menopause. The timing of menopause is moderately linked to longevity: later menopause (after 55) is associated with longer lifespan but also higher breast cancer risk; early menopause (before 45) is linked to increased cardiovascular disease and osteoporosis, potentially shortening lifespan. However, these effects are multifactorial – genetics, lifestyle, and environment play larger roles. The test itself does not directly measure longevity but provides a hormonal snapshot that can inform personalized health strategies. Evidence is based on epidemiological studies (moderate), not RCTs. Be cautious of overblown claims: a hormone panel alone does not predict actual lifespan. Medical follow-up for abnormal results is recommended.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-be7cf7238f83e56c8923b28c